Cargando…
New Antimicrobial Bioactivity against Multidrug-Resistant Gram-Positive Bacteria of Kinase Inhibitor IMD0354
Multidrug-resistant pathogens pose a serious threat to human health. For decades, the antibiotic vancomycin has been a potent option when treating Gram-positive multidrug-resistant infections. Nonetheless, in recent decades, we have begun to see an increase in vancomycin-resistant bacteria. Here, we...
Autores principales: | Escobar, Iliana E, White, Alexis, Kim, Wooseong, Mylonakis, Eleftherios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601562/ https://www.ncbi.nlm.nih.gov/pubmed/33019726 http://dx.doi.org/10.3390/antibiotics9100665 |
Ejemplares similares
-
The novel NF-κB inhibitor IMD-0354 induces apoptosis in chronic lymphocytic leukemia
por: Kanduri, M, et al.
Publicado: (2011) -
Studies on the treatment of melanoma with folate acid conjugated dextran and lauryl alcohol loaded with IMD0354
por: Liu, Can, et al.
Publicado: (2019) -
IKKβ Inhibitor IMD-0354 Attenuates Radiation Damage in Whole-body X-Irradiated Mice
por: Waga, Kengo, et al.
Publicado: (2019) -
IMD-0354 Targets Breast Cancer Stem Cells: A Novel Approach for an Adjuvant to Chemotherapy to Prevent Multidrug Resistance in a Murine Model
por: Gomez-Cabrero, Azucena, et al.
Publicado: (2013) -
The emerging role of IMD 0354 on bone homeostasis by suppressing osteoclastogenesis and bone resorption, but without affecting bone formation
por: Chen, Wenxiang, et al.
Publicado: (2019)